FK506 increases permeability in rat intestine by inhibiting mitochondrial function☆
References (48)
- et al.
The mechanism of action of CyA and FK506
Immunol Today
(1992) - et al.
Calcineurin is a common target of cyclophilin-CyA and FKBP-FK506 complexes
Cell
(1991) - et al.
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression
Trends Biochem Sci
(1993) - et al.
Diabetogenic effects of FK506 on renal subcapsular islet isografts in rats
Diabetes Res Clin Pract
(1993) - et al.
Comparison of the effects of the immunosuppressive agents FK506 and cyclosporin A on rat kidney mitochondria
Biochem Pharmacol
(1993) - et al.
Nutrient utilization by cells isolated from rat jejunum, caecum, and colon
J Nutr
(1991) - et al.
Nutrient oxidation by rat intestinal epithelial cells is concentration dependent
J Nutr
(1993) - et al.
A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-EDTA absorption test
Lancet
(1983) - et al.
The leaky gut of alcoholism: route of entry for toxic compounds
Lancet
(1984) - et al.
Absorption of 51-chromium-labelled ethylenediaminetetraacetate in inflammatory bowel disease
Gastroenterology
(1983)
Glucose and citrate reduce the permeability changes caused by indomethacin in humans
Gastroenterology
(1992)
Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein
Cell
(1994)
FK506 (Tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects
Clin Chem
(1993)
The immunosuppressant FK506 selectively inhibits the expression of early T cell activation genes
J Immunol
(1989)
Evidence that the immunosuppressive effects of FK506 and cyclosporin are identical
Transplantation
(1990)
Selective suppression of an early step in human B-cell activation by cyclosporin A
J Exp Med
(1983)
The use of FK506 for small intestine allotransplantation: inhibition of acute rejection and prevention of fatal graft-versus-host disease
Transplantation
(1990)
Effect of FK506 on bowel transplantation in rats
Transplant Proc
(1992)
A randomized trial of primary liver transplantation under immunosuppression with FK506 vs cyclosporin
Transplant Proc
(1991)
Clinical intestinal transplantation: three year experience
Intestinal transplantation in humans under FK506
Transplant Proc
(1993)
Kidney transplantation under FK506
JAMA
(1990)
Uncoupling of the molecular ‘fence’ and paracellular ‘gate’ functions in epithelial tight junctions
Nature
(1993)
Gastrointestinal mucosal injury in experimental models of shock, trauma and sepsis
Crit Care Med
(1991)
Cited by (80)
Risk factors and evolution of IgE-mediated food allergies before and after liver transplantation in a French pediatric cohort
2022, Revue Francaise d'AllergologieImmunological and Other Late Complications
2020, Pediatric Liver TransplantationAcquired IgE-mediated food allergy after liver transplantation in children
2015, Allergologia et ImmunopathologiaCitation Excerpt :It was also determined that the use of tacrolimus as an immunosuppressant agent and tacrolimus blood levels were not associated with IgE-mediated food allergies, but peripheral eosinophil and serum total IgE levels were significantly higher in patients who developed IgE-mediated food allergies. Previous studies have reported that the incidence of IgE- and/or non-IgE-mediated food allergy after liver transplantation ranges from 8.5% to 37.6%.1,5,9 It was reported in these studies that patients mostly developed allergic reactions to eggs and milk.
Pediatric food allergy and mucosal tolerance
2010, Mucosal Immunology
- ☆
Supported by the Medical Research Council of Canada and the Alberta Heritage Foundation.
Copyright © 1995 Published by Elsevier Inc.